Anthrax laboratory findings: Difference between revisions
Jump to navigation
Jump to search
Joao Silva (talk | contribs) |
Joao Silva (talk | contribs) |
||
Line 20: | Line 20: | ||
|- | |- | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[Electrolyte]], [[Renal]] Panel, [[Lactate]] Level''' | | style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[Electrolyte]], [[Renal]] Panel, [[Lactate]] Level''' | ||
| style="background: #DCDCDC; padding: 5px;"| Decreased [[Na]] level<br>Increased [[BUN]] | | style="background: #DCDCDC; padding: 5px;"| Decreased [[Na+]] level<br>Increased [[BUN]] | ||
| style="background: #DCDCDC; padding: 5px;"| | | style="background: #DCDCDC; padding: 5px;"| | ||
|- | |- | ||
Line 29: | Line 29: | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[PT]], [[PTT]], [[D-dimer]], [[Fibrinogen]]''' | | style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[PT]], [[PTT]], [[D-dimer]], [[Fibrinogen]]''' | ||
| style="background: #DCDCDC; padding: 5px;"| Normal [[PT]]/[[PTT]] does not exclude [[DIC]] or [[coagulopathy]] | | style="background: #DCDCDC; padding: 5px;"| Normal [[PT]]/[[PTT]] does not exclude [[DIC]] or [[coagulopathy]] | ||
| style="background: #DCDCDC; padding: 5px;"| | | style="background: #DCDCDC; padding: 5px;"| Low threshold for hypercoagulability workup:<br>[[Haptoglobin]]<br>[[LDH]]<br>[[Fibrin]] split products<br>ADAMTS 13 if [[hemolytic anemia]] | ||
|- | |- | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[C-Reactive Protein]]''' | | style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[C-Reactive Protein]]''' | ||
| style="background: #DCDCDC; padding: 5px;"| [[]] | | style="background: #DCDCDC; padding: 5px;"| Characterization of Inflammatory Response<br>Typically low [[CRP]] in injection [[anthrax]] | ||
| style="background: #DCDCDC; padding: 5px;"| | | style="background: #DCDCDC; padding: 5px;"| | ||
|- | |- | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[Gram Stain]], [[Cell cultures|Cultures]], Toxic Assays''' | | style="background: #F5F5F5; padding: 5px; text-align: center;"| '''[[Gram Stain]], [[Cell cultures|Cultures]], Toxic Assays''' | ||
| style="background: #DCDCDC; padding: 5px;"| [[]] | | style="background: #DCDCDC; padding: 5px;"| [[Blood]]<br>[[Serum]]<br>[[CSF]]<br>[[Pleural fluid]]<br>[[Ascites]]<br>Wound [[exudate]]<br>[[Bronchial]] [[exudate]] | ||
| style="background: #DCDCDC; padding: 5px;"| [[]] | | style="background: #DCDCDC; padding: 5px;"| [[]] | ||
|} | |} |
Revision as of 23:27, 16 July 2014
Anthrax Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Anthrax laboratory findings On the Web |
American Roentgen Ray Society Images of Anthrax laboratory findings |
Risk calculators and risk factors for Anthrax laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Laboratory Findings
The following tests are used in the diagnosis and monitoring of systemic anthrax:[1]
Test | Initial Findings | Serial Monitoring |
---|---|---|
CBC | Hemoconcentration Possible Thrombocytopenia Leukocyte count commonly normal |
Anemia Thrombocytopenia Leukocytosis (late in disease) |
Electrolyte, Renal Panel, Lactate Level | Decreased Na+ level Increased BUN |
|
Liver Enzymes, Serum Albumin | Elevated transaminase levels hypoalbuminemia |
|
PT, PTT, D-dimer, Fibrinogen | Normal PT/PTT does not exclude DIC or coagulopathy | Low threshold for hypercoagulability workup: Haptoglobin LDH Fibrin split products ADAMTS 13 if hemolytic anemia |
C-Reactive Protein | Characterization of Inflammatory Response Typically low CRP in injection anthrax |
|
Gram Stain, Cultures, Toxic Assays | Blood Serum CSF Pleural fluid Ascites Wound exudate Bronchial exudate |
[[]] |
References
- ↑ Hendricks, Katherine A.; Wright, Mary E.; Shadomy, Sean V.; Bradley, John S.; Morrow, Meredith G.; Pavia, Andy T.; Rubinstein, Ethan; Holty, Jon-Erik C.; Messonnier, Nancy E.; Smith, Theresa L.; Pesik, Nicki; Treadwell, Tracee A.; Bower, William A. (2014). "Centers for Disease Control and Prevention Expert Panel Meetings on Prevention and Treatment of Anthrax in Adults". Emerging Infectious Diseases. 20 (2). doi:10.3201/eid2002.130687. ISSN 1080-6040.